Non-contact navigated laser retinopexy for peripheral retinal tears and rhegmatogenous degenerations: first experience

2021 ◽  
Vol 137 (1) ◽  
pp. 46
Author(s):  
V.A. Shaimova ◽  
T.B. Shaimov ◽  
A.N. Kulikov ◽  
R.B. Shaimov ◽  
D.S. Maltsev ◽  
...  
Keyword(s):  
Retinal Tears ◽  
Navigated Laser

Internal limiting membrane graft as a treatment for the retinal detachment secondary to an optic disc coloboma

2021 ◽  
pp. 112067212199268
Author(s):  
Jorge Fernández-Engroba ◽  
Muhsen Saman ◽  
Jeroni Nadal
Keyword(s):  
Visual Acuity ◽  
Retinal Detachment ◽  
Optic Disc ◽  
Subretinal Fluid ◽  
Visual Outcome ◽  
Internal Limiting Membrane ◽  
Subretinal Space ◽  
Direct Closure ◽  
Retinal Tears ◽  
Optic Disc Coloboma

Purpose: To report our anatomical outcome with the internal limiting membrane (ILM) graft procedure in the management of rhegmatogenous retinal detachment (RRD) secondary to optic disc coloboma (ODC). Methods: Description of a new surgical procedure in one eye of one patient who underwent pars plana vitrectomy (PPV) combined with ILM graft technique. Subsequent follow-up included optical coherence tomography (OCT) and visual acuity. Results: After only 1 week, the OCT revealed the ILM graft plugging the retinal tear with complete resorption of subretinal fluid. The sealing effect of this graft persisted after 6 months. However, visual outcome was poor and corrected distance visual acuity was 20/200 as a result of the previous long-standing retinal detachment with loss of photoreceptors. Conclusion: We suggest that ILM graft could be performed as a first line treatment in the management of RRD secondary to ODC. This direct closure of the retinal tears, allows a quick and effective interruption of the communication between the subretinal space and the vitreous cavity. Detecting these retinal tears and applying this technique as soon as possible could achieve not only an earlier anatomical success but obtain good visual results in retinal tears with RRD secondary to ODC. Further studies will be necessary to provide more evidences

Idiopathic giant retinal tears in identical twins

1999 ◽  
Vol 127 (1) ◽  
pp. 96-99 ◽  
Author(s):  
Nauman A Chaudhry ◽  
Harry W Flynn ◽  
Homayoun Tabandeh
Keyword(s):  
Identical Twins ◽  
Retinal Tears

scholarly journals Surgical treatment and outcome of patients with giant retinal tears

Eye ◽  
2004 ◽  
Vol 18 (10) ◽  
pp. 996-1000 ◽  
Author(s):  
Y K Ghosh ◽  
S Banerjee ◽  
V Savant ◽  
V Kotamarthi ◽  
M T Benson ◽  
...  
Keyword(s):  
Surgical Treatment ◽  
Retinal Tears

Giant Retinal Tears

1986 ◽  
pp. 177-188
Author(s):  
Ronald G. Michels
Keyword(s):  
Retinal Tears

scholarly journals Use of Anti-VEGF Agents and Lasers in Behçet s Disease

2018 ◽  
pp. 376-379
Keyword(s):  
Macular Edema ◽  
Laser Treatment ◽  
Cystoid Macular Edema ◽  
Secondary Glaucoma ◽  
Secondary Cataract ◽  
Anti Vegf ◽  
Functional Benefit ◽  
Management Of Complications ◽  
Retinal Tears

Ocular form of Behçet s Disease may end up in several complications. Anti-vasculoendothelial (anti-VEGF) agents and/or laser treatment are used in the management of these complications. Intravitreal Anti-VEGF agents are employed in Behçet s Disease for the management of cystoid macular edema (CME) and neovascularization (NV). Bevacizumab is reported to be effective for CME in some studies, however, there are also articles reporting that it does not provide significant anatomic or functional benefit. In Behçet s Disease laser treatment is indispensable in the management of complications like secondary glaucoma, secondary cataract, retinal tears, and retinal NV.

Perfluorocarbon in the Treatment of Giant Retinal Tears

Ophthalmology ◽  
1993 ◽  
Vol 100 (5) ◽  
pp. 581
Author(s):  
Alan Luckie ◽  
Everett Ai ◽  
Wayne Fling
Keyword(s):  
Retinal Tears
Sign in / Sign up

Export Citation Format

Share Document